Outome measures
Peripheral neuropathy, Cancer
ONCOLOGY, PERIPHERAL NEUROPATHY, CANCER
Peripheral neuropathy was assessed with a validated patient-reported outcome measure, the Functional Assessment of Cancer Therapy/Gynaecologic Oncology Group-Neurotoxicity 4 (FACT/GOG-NTX-4) tool.